HEMOLYTIC-UREMIC SYNDROME WITH ANTICARDIOLIPIN ANTIBODIES REVEALING PARANEOPLASTIC SYSTEMIC SCLERODERMA

被引:13
作者
MEYRIER, A
BECQUEMONT, L
WEILL, B
CALLARD, P
RAINFRAY, M
机构
[1] HOP COCHIN,IMMUNOL CLIN LAB,F-75674 PARIS 14,FRANCE
[2] HOP JEAN VERDIER,ANAT PATHOL LAB,F-93140 BONDY,FRANCE
来源
NEPHRON | 1991年 / 59卷 / 03期
关键词
HEMOLYTIC-UREMIC SYNDROME; CANCER OF THE PROSTATE; ACUTE RENAL FAILURE; SYSTEMIC SCLERODERMA; LUPUS ANTICOAGULANT; ANTIPHOSPHOLIPID ANTIBODIES;
D O I
10.1159/000186616
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Lupus anticoagulant was present in this case of paraneoplastic scleroderma revealed by hemolytic-uremic syndrome, suggesting that the autoantibody played a significant role in the sequence of events leading to anuria. Reviewing the literature we found several observations of paraneoplastic scleroderma, and in other series cases of scleroderma-linked (and in rare instances cancer-linked) antiphospholipid autoantibodies. Search for antiphospholipid antibodies should be considered in patients with systemic scleroderma as well as in patients with metastatic cancer. Presence of such procoagulant autoantibodies might predict future complications and should influence treatment strategy.
引用
收藏
页码:493 / 496
页数:4
相关论文
共 21 条
[1]   ANTIPHOSPHOLIPID ANTIBODIES AND THE ANTIPHOSPHOLIPID SYNDROME IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A PROSPECTIVE ANALYSIS OF 500 CONSECUTIVE PATIENTS [J].
ALARCONSEGOVIA, D ;
DELEZE, M ;
ORIA, CV ;
SANCHEZGUERRERO, J ;
GOMEZPACHECO, L ;
CABIEDES, J ;
FERNANDEZ, L ;
DELEON, SP .
MEDICINE, 1989, 68 (06) :353-365
[2]   THE PRIMARY ANTIPHOSPHOLIPID SYNDROME - MAJOR CLINICAL AND SEROLOGICAL FEATURES [J].
ASHERSON, RA ;
KHAMASHTA, MA ;
ORDIROS, J ;
DERKSEN, RHWM ;
MACHIN, SJ ;
BARQUINERO, J ;
OUTT, HH ;
HARRIS, EN ;
VILARDELLTORRES, M ;
HUGHES, GRV .
MEDICINE, 1989, 68 (06) :366-374
[3]   LUPUS ANTICOAGULANT ASSOCIATED SYNDROME IN BENIGN AND MALIGNANT SYSTEMIC-DISEASE - ANALYSIS OF 10 OBSERVATIONS [J].
DUHRSEN, U ;
PAAR, D ;
KOLBEL, C ;
BOEKSTEGERS, A ;
METZKURSCHEL, U ;
WAGNER, R ;
KIRCH, W ;
MEUSERS, P ;
KONIG, E ;
BRITTINGER, G .
KLINISCHE WOCHENSCHRIFT, 1987, 65 (18) :852-859
[4]   THROMBOSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - RELATION TO THE PRESENCE OF CIRCULATING ANTICOAGULANTS [J].
GLUECK, HI ;
KANT, KS ;
WEISS, MA ;
POLLAK, VE ;
MILLER, MA ;
COOTS, M .
ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (08) :1389-1395
[5]   USE OF AN ENZYME-LINKED IMMUNOSORBENT-ASSAY AND OF INHIBITION STUDIES TO DISTINGUISH BETWEEN ANTIBODIES TO CARDIOLIPIN FROM PATIENTS WITH SYPHILIS OR AUTOIMMUNE DISORDERS [J].
HARRIS, EN ;
GHARAVI, AE ;
WASLEY, GD ;
HUGHES, GRV .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (01) :23-31
[6]  
HUGHES GRV, 1986, J RHEUMATOL, V13, P486
[7]   RECURRENT HEMOLYTIC UREMIC SYNDROME IN THE ELDERLY ASSOCIATED WITH METASTATIC CARCINOMA [J].
INNES, A ;
BERNARD, T ;
COTTON, RE ;
BURDEN, RP .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1990, 5 (10) :886-888
[8]  
JULIOT AY, 1979, NOUV PRESSE MED, V8, P703
[9]   GLOMERULAR THROMBOSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - PREVALENCE AND SIGNIFICANCE [J].
KANT, KS ;
POLLAK, VE ;
WEISS, MA ;
GLUECK, HI ;
MILLER, MA ;
HESS, EV .
MEDICINE, 1981, 60 (02) :71-86
[10]  
KINCAIDSMITH P, 1988, Q J MED, V69, P795